These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 11268997)

  • 1. Cholangiocarcinoma and the role of radiation and chemotherapy.
    Price P
    Hepatogastroenterology; 2001; 48(37):51-2. PubMed ID: 11268997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial chemotherapy and conformal radiation abolish malignant biliary obstruction.
    Guan YS; Qing He ; Ping Li ; Fu YC; Zhao SW
    Integr Cancer Ther; 2008 Mar; 7(1):51-3. PubMed ID: 18292595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment.
    Demols A; Maréchal R; Devière J; Van Laethem JL
    Best Pract Res Clin Gastroenterol; 2007; 21(6):1015-29. PubMed ID: 18070701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of cholangiocarcinomas: a comprehensive review.
    Yalcin S
    Hepatogastroenterology; 2004; 51(55):43-50. PubMed ID: 15011829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
    Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
    Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostics and treatment of cholangiocarcinoma].
    Mantel HT; Verdonk RC; van Dullemen HM; Gietema JA; Slooff MJ; Porte RJ
    Ned Tijdschr Geneeskd; 2008 May; 152(18):1037-41. PubMed ID: 18547024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.
    Ben-Josef E; Normolle D; Ensminger WD; Walker S; Tatro D; Ten Haken RK; Knol J; Dawson LA; Pan C; Lawrence TS
    J Clin Oncol; 2005 Dec; 23(34):8739-47. PubMed ID: 16314634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy for resected extrahepatic cholangiocarcinoma: a review of the literature and future directions.
    Anderson C; Kim R
    Cancer Treat Rev; 2009 Jun; 35(4):322-7. PubMed ID: 19147294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of liver transplantation in the treatment of cholangiocarcinoma.
    Singal A; Welling TH; Marrero JA
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):491-502. PubMed ID: 19374602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eleven-year survivor of unresectable intrahepatic cholangiocarcinoma treated using long-term UFT therapy.
    Takemura N; Kokudo N; Imamura H; Takazawa Y; Sano K; Sugawara Y; Nakagawa K; Ohtomo K; Makuuchi M
    Hepatogastroenterology; 2008; 55(88):1997-9. PubMed ID: 19260466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locoregional intra-arterial therapies for unresectable intrahepatic cholangiocarcinoma.
    Hong K; Geschwind JF
    Semin Oncol; 2010 Apr; 37(2):110-7. PubMed ID: 20494703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
    Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
    Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy.
    Kelley ST; Bloomston M; Serafini F; Carey LC; Karl RC; Zervos E; Goldin S; Rosemurgy P; Rosemurgy AS
    Am Surg; 2004 Sep; 70(9):743-8; discussion 748-9. PubMed ID: 15481288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma.
    Mantel HT; Rosen CB; Heimbach JK; Nyberg SL; Ishitani MB; Andrews JC; McKusick MA; Haddock MG; Alberts SR; Gores GJ
    Liver Transpl; 2007 Oct; 13(10):1372-81. PubMed ID: 17427173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A 42-month disease free survival case of combined hepatocellular-cholangiocarcinoma with lymph node metastases treated with multimodal therapy].
    Hayashi H; Beppu T; Ishiko T; Mizumoto T; Masuda T; Okabe K; Baba Y; Okabe H; Takamori H; Kanemitsu K; Hiroto M; Baba H
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1941-3. PubMed ID: 17212153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Palliative therapy of inoperable cholangiocarcinoma].
    Gerhardt T; Mey U; Sauerbruch T; Dumoulin FL
    Dtsch Med Wochenschr; 2002 Sep; 127(36):1835-9. PubMed ID: 12215930
    [No Abstract]   [Full Text] [Related]  

  • 17. Unresectable hilar cholangiocarcinoma: multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy.
    Golfieri R; Giampalma E; Renzulli M; Galuppi A; Vicenzi L; Galaverni MC; Cappelli A
    In Vivo; 2006; 20(6A):757-60. PubMed ID: 17203762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the anti-epidermal growth factor receptor antibody cetuximab on cholangiocarcinoma of the liver.
    Huang TW; Wang CH; Hsieh CB
    Onkologie; 2007 Mar; 30(3):129-31. PubMed ID: 17341899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regional chemotherapy in experimental cholangiocarcinoma in pigs].
    Dufek V; Petrtýl J
    Cas Lek Cesk; 1998 Aug; 137(15):464-6. PubMed ID: 9748745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery.
    Todoroki T
    Hepatogastroenterology; 2000; 47(33):644-9. PubMed ID: 10919004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.